- Inactivated Vaccines
- Recombinant vaccines
- Live attenuated vaccines
- DNA vaccines
- Subunit vaccines
Swine Vaccines Market size is expected to be valued at USD 1,632.1 million in 2021 and is expected to grow at a CAGR of 5.1% during the forecast period 2022 to 2028. The global market provides a detailed overview of the swine vaccines market and which can be segmented by vaccine type, disease type, distribution channel, and region. By vaccine type, the swine vaccines market has been segmented into inactivated vaccines, recombinant vaccines, live attenuated vaccines, DNA vaccines, subunit vaccines, and others. By vaccine type, the inactivated vaccines segment dominated the market and registered for having a significant revenue share of XX% during 2022-2028 owing to its easy availability, reasonable cost, and stability advantages over live-attenuated vaccines. Â Also, it minimizes the risk of virulence reversion after vaccination, as it prevents the replication process of pathogens. Furthermore, it offers swine better immunization with a rapid cell-mediated immune response. Immunity obtained from inactivated vaccines can be further improved with adjuvants such as certain types of oils or aluminum hydroxide. By disease type, the swine vaccine market has been segmented into viral infections, bacterial infections, parasitic infections, fungal infections, and others. By disease type, the viral infections segment held the largest revenue share of the swine vaccines market in the past few years and is projected to have a rapid growth rate over the forecasted period due to continuous increasing viral infections among a large part of the population due to various swine diseases. Based on the distribution channel, the segment has been segregated into veterinary hospitals, veterinary pharmacies, and online pharmacies. The online pharmacies segment is expected to lead the distribution channel segments during the forecasted period with a significant market share.
Fastest Growing Market
Rising swine disease outbreaks primarily drive the market. Also, some highly contagious swine diseases such as porcine reproductive and respiratory syndrome (PRRS) and swine influenza remain to be increasing in prevalence among swine herds in Asia, Europe, and American regions contributing to severe economic loss. Thus, to curb the effect swine producers are widely implementing biosecurity measures and vaccination processes. These factors will expect to expand the swine vaccines market globally in the upcoming few years.
Based on the vaccine type, the inactivated vaccines segment dominated and accounted for the largest revenue share of about 31.0% in 2021 attributable due to easy accessibility, low cost, nominal risk of revert reaction of killed viruses, and continuous new improvements by prominent players.
The major factors driving the market growth are the increasing prevalence of diseases in swine, the upsurges in the demand for animal protein, and the advancement in vaccination services.
Increasing awareness about the importance of animal health and the rising demand for meat & poultry products are expected to drive market growth.